Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830511) titled 'RIsk aDapted Stereotactic Radiotherapy vs. standarD of Care Radiotherapy in Patients With Prostate Cancer in the Adjuvant or saLvage sEtting With or Without Lymph Node Irradiation (RIDDLELN) - A Phase III Trial' on Sept. 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Robert Forster
Condition:
Prostate Cancer (Post Prostatectomy)
Prostate Cancer
SBRT
Intervention:
Radiation: Stereotactic body radiotherapy (SBRT) to the prostate bed
Recruitment Status: Not recruiting
Phase: P...